Skip to main content
OpenTrials
Completed

NCT Number: NCT04378842

COVID-19 and ICU-acquired MDR Bacteria

This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sars-CoV2 COVID-19 Coronaviridae Infections Coronavirus Infections Critical Illness Disease Attributes Infections Lung Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Amiens Picardie, Amiens, France

Loading trial locations.

About this study

Multicenter observational before-after study, aiming to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to MDR bacteria.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Expected ICU stay > 48 hours
  • Rectal and nasal BMR screening performed < 48 hours after admission to ICU

Exclusion criteria

  • Patients aged < 18 years Refusal to take part in the study ICU-stay < 48 hours At least a second rectal and nasal BMR screening was not performed prior to ICU discharge (a posteriori exclusion criterion).

Treatment and study plan

Primary outcomes

  1. Cumulative incidence of ICU-acquired colonization related multidrug resistant bacteria

    Time frame: from D3 until day 28 after ICU admission

    percentage of patients with ICU acquired MDR bacteria colonization

Secondary outcomes

  1. Cumulative incidence of ICU-acquired infection related to multidrug resistant bacteria

    Time frame: from D3 until day 28 after ICU admission

    percentage of patients with ICU acquired MDR bacteria infection

  2. Mechanical ventilation duration

    Time frame: from D1 until day 28 after ICU admission

    the number of days Under mechanical ventilation

  3. mortality

    Time frame: from D1 until day 28 after ICU admission

    death in the ICU

  4. length of stay in intensive care unit

    Time frame: from D1 until day 28 after ICU admission

    the number of days of hospitalization in the ICU

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Registry information

Official study title

Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria

Acronym: COVID-BMR

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 7, 2020
Registry last updated
Apr 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.